483
ABO Plasma Glassboro LLCFDA 483 - ABO Plasma Glassboro LLC - March 14, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of ABO Plasma Glassboro LLC, a plasmapheresis center, revealed a significant failure in donor notification procedures. The firm did not make reasonable attempts to notify deferred donors within the required 8-week period, specifically for HCV reactive donors. This indicates a serious lapse in donor safety and regulatory compliance.
Open in Dashboard
ID · 950fad97-070d-4c31-9755-5adfb68ef661